Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Roland Rad, Thomas Engleitner et al.|Nature|2018Cited by 455
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolutionAnja Fischer, Roland Rad, Robert Lersch et al.|Cell Genomics|2023Cited by 10
Histopathologische Forschungslabors in der translationalen ForschungKatja Steiger, Carolin Mogler, Simone Ballke et al.|Der Pathologe|2018Cited by 7
Abstract 391: Evolutionary trajectories and <i>KRAS</i> gene dosage define pancreatic cancer phenotypesSebastian Mueller, Roland Rad, Thomas Engleitner et al.|Cancer Research|2018Cited by 0
Histopathologische Forschungslabors in der translationalen Forschung: Konzeption sowie Integration in die Infrastruktur pathologischer InstituteKatja Steiger, Carolin Mogler, Hsi-Yu Yen et al.|Der Pathologe|2019Cited by 0